BIOGENIX CURE MONODOSE, SUSPENSION INJECTABLE POUR CHIENS
BIOGENIX CURE MONODOSE, SUSPENSION INJECTABLE POUR CHIENS
Authorised
- ALLERGENS
Product identification
Medicine name:
BIOGENIX CURE MONODOSE, SUSPENSION INJECTABLE POUR CHIENS
Active substance:
- ALLERGENS
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
ALLERGENS1.00/unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QV01AA
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Available in:
-
France
Package description:
- Available only in French
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Bibliographic application (Article 22 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva Biovac
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/8194783 4/2024
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 1/04/2026
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 1/04/2026
